IRCT2015081723651N1已完成1 期
Evaluation of the effectiveness of ZIV-aflibercept (Zal-trap) in patients with retinal vascular disorders resistant to Avastin
Investigator0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion criteria :Eyes with active neovascularage-related macular degeneration (AMD) or diabetic macular edema (DME), best-corrected visual acuity of 20/100 (6/30) or less, the ability to comprehend the risks and benefits of the study, and the ability to sign the consent form; Exclusion criteria : Signs of ocular infection and a history of myocardial infarction or cerebrovascular accident.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Safety and efficacy of ziv Aflibercept compounding in refractory diabetic macular oedemaACTRN12616000012471Dr Andrew Riley40
终止
3 期
Efficacy and safety of intravitreal Ziv-aflibercept injection for the treatment of refractory diabetic macula edemaDiabetic macular edemaDiabetes mellitusDiabetic macular edemaOphthalmic complications of diabetes mellitusZiv-afliberceptBevacizumabintravitreal injectionanti-vascular endothelial growth factorsTCTR20191130001Faculty of Medicine, Khon Kaen University7
已完成
不适用
Investigation of clinical efficacy for Aflibercept in patients with polypoidal choroidal vasculopathy (PCV)Polypoidal Choroidal VasculopathyJPRN-UMIN000011091Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University50
已完成
不适用
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathyJPRN-UMIN000010461Yokohama City University Medical Center30
已完成
4 期
An observational study of Livogen Z tablet in patients with iron deficiency anemiaCTRI/2023/04/051785Procter and Gamble Health Limited102